Sei Investments Co. increased its position in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 59.2% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 811,857 shares of the software maker’s stock after buying an additional 301,803 shares during the period. Sei Investments Co.’s holdings in Allscripts Healthcare Solutions were worth $10,359,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the company. FNY Partners Fund LP boosted its position in Allscripts Healthcare Solutions by 900.0% in the first quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock worth $101,000 after buying an additional 7,200 shares in the last quarter. Invictus RG bought a new position in Allscripts Healthcare Solutions during the first quarter worth $105,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Allscripts Healthcare Solutions by 9.5% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,434 shares of the software maker’s stock worth $120,000 after buying an additional 816 shares in the last quarter. Bank of Montreal Can boosted its position in Allscripts Healthcare Solutions by 60.2% in the first quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock worth $126,000 after buying an additional 3,724 shares in the last quarter. Finally, Flinton Capital Management LLC boosted its position in Allscripts Healthcare Solutions by 4.1% in the first quarter. Flinton Capital Management LLC now owns 9,940 shares of the software maker’s stock worth $126,000 after buying an additional 392 shares in the last quarter.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) opened at 12.35 on Friday. The stock’s market cap is $2.23 billion. Allscripts Healthcare Solutions, Inc. has a one year low of $9.80 and a one year high of $13.70. The company has a 50 day moving average of $12.50 and a 200-day moving average of $12.15.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by $0.04. The company had revenue of $426.10 million for the quarter, compared to analysts’ expectations of $424.94 million. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The company’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.14 EPS. On average, analysts anticipate that Allscripts Healthcare Solutions, Inc. will post $0.62 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This news story was first published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another website, it was stolen and reposted in violation of United States & international trademark & copyright law. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/08/11/allscripts-healthcare-solutions-inc-nasdaqmdrx-shares-bought-by-sei-investments-co.html.

A number of research firms have weighed in on MDRX. Bank of America Corporation began coverage on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. They set a “neutral” rating and a $14.00 price objective for the company. Leerink Swann cut shares of Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $15.00 to $13.00 in a research report on Monday, June 19th. Cantor Fitzgerald restated a “neutral” rating and set a $13.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. BidaskClub upgraded shares of Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. Finally, Maxim Group restated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Friday, May 5th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have given a buy rating to the company. Allscripts Healthcare Solutions presently has a consensus rating of “Hold” and a consensus target price of $14.66.

In related news, President Richard J. Poulton sold 25,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $12.06, for a total transaction of $301,500.00. Following the completion of the sale, the president now owns 412,488 shares in the company, valued at approximately $4,974,605.28. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.75% of the company’s stock.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.